Fierce Pharma4h
In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in
As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
The Financial Express5h
Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity
Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their ...
Novo Nordisk slashes Wegovy price for patients lacking insurance benefits
Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...
USA TODAY on MSN12d
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's ...
CNN on MSN12d
Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
The Washington Post13d
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The company promoted its weight-loss offerings in a Super Bowl ad as “affordable ... stomach from emptying and sending a ...